HRAS and cancer: Interestingly, whilst the spectrum of variants in KRAS/HRAS in human cancer typically involves activating missense variants at codons 12, 13, and 6134, KRAS/HRAS in-frame indels or in-frame duplications have been associated with vascular malformations26,31.